Lilly Marks - Dec 31, 2022 Form 5 Insider Report for Orthofix Medical Inc. (OFIX)

Role
Director
Signature
/s/ Kimberley Elting, President, Global Orthopedics, by power of attorney
Stock symbol
OFIX
Transactions as of
Dec 31, 2022
Transactions value $
$3,999
Form type
5
Date filed
1/11/2023, 03:50 PM
Previous filing
Jun 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OFIX Common Stock Award $4K +293 +0.78% $13.65 37.8K Oct 31, 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Lilly Marks is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 Shares purchased pursuant to the Orthofix Medical Inc. Second Amended and Restated Stock Purchase Plan, as Amended (the "Stock Purchase Plan") for the plan period ended October 31, 2022.
F2 Pursuant to the terms of the Stock Purchase Plan, shares are purchased at 85% of the fair market value of the Orthofix stock on the first day of the plan period or, if lower, on the last day of the plan period. Accordingly, shares were purchased at $13.65 per share, or at 85% of the quoted market price of $16.06 on October 31, 2022.